Show simple item record

FieldValueLanguage
dc.contributor.authorTavakolian, Alirezaen
dc.contributor.authorHajati, Farshiden
dc.contributor.authorRezaee, Alirezaen
dc.contributor.authorFasakhodi, Amirhossein Oliaeien
dc.contributor.authorUddin, Shahadaten
dc.date.accessioned2022-07-04T00:45:43Z
dc.date.available2022-07-04T00:45:43Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/2123/28995
dc.description.abstractCOVID-19 and swine-origin influenza A (H1N1) are both pandemics that sparked significant concern worldwide. Since these two diseases have common symptoms, a fast COVID-19 versus H1N1 screening helps better manage patients at healthcare facilities. We present a novel deep model, called Optimized Parallel Inception, for fast screening of COVID-19 and H1N1 patients. We also present a Semi-supervised Generative Adversarial Network (SGAN) to address the problem related to the smaller size of the COVID-19 and H1N1 research data. To evaluate the proposed models, we have merged two separate COVID-19 and H1N1 data from different sources to build a new dataset. The created dataset includes 4,383 positive COVID-19 cases, 989 positive H1N1 cases, and 1,059 negative cases. We applied SGAN on this dataset to remove issues related to unequal class densities. The experimental results show that the proposed model's screening accuracy is 99.2% and 99.6% for COVID-19 and H1N1, respectively. According to our analysis, the most significant symptoms and underlying chronic diseases for COVID-19 versus H1N1 screening are dry cough, breathing problems, diabetes, and gastrointestinal.en
dc.language.isoenen
dc.rightsOther
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.titleFast COVID-19 versus H1N1 screening using Optimized Parallel Inceptionen
dc.typeArticleen
dc.identifier.doi10.1016/j.eswa.2022.117551
usyd.facultyFaculty of Engineeringen


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.